GenScript Biotech Corporation is a leading life science research, application service, and product provider. It applies its proprietary technology to various fields, from basic life sciences research to translational biomedical development, industrial synthetic products, and cell therapeutic solutions. After almost two decades of rapid growth, the company has expanded its business in recent years into the fields of immunotherapy, CDMO and microbiology to further its core mission of making people and nature healthier through biotechnological innovation.
GenScript ProBio is the biopharmaceutical CDMO segment of the world's leading biotech company GenScript Biotech Corporation. One-stop antibody drug development solutions include antibody drug discovery, antibody engineering, antibody development, and clinical and commercial manufacturing. Process development quality systems ensure compliance, data integrity and traceability, and all test deviations are strictly studied and documented. With the principle of "providing the best-in-class quality to and serving customers' interests", GenScript ProBio is committed to helping customers shorten the timeline. Such as biological drugs from development to clinical use, significantly cutting down the R&D costs, accelerating the commercialization of medicines, and building a healthy future while contributing to the development of the pharmaceutical industry.
website